Bibliography
- NORMAN P: Developing anti- inflammatory drugs for the treatment of COPD. Intim Res. in press
- •Up-to-date review of the area.
- STOCKLEY RA: Proteases and antiproteases. Novartis Found. Symp. (2001) 234:189–199
- ••Excellent description of this keyhypothesis.
- BERNSTEIN PR, EDWARDS PD, WILLIAMS JC: Inhibitors of human leukocyte elastase. Frog. Med. Chem. (1994) 31:59–120
- ••Excellent review of earlier chemicalapproaches to this target.
- TREMBLAY GM, JANELLE MF, BOURBONNAIS Y: Anti-inflammatory activity of neutrophil elastase inhibitors. Curr. Opin. Investig. Drugs (2003) 4:556–565.
- •Recent review of what has been an intensively targeted area.
- BELVISI MG, BOTTOMLEY KM: The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm. Res. (2003) 52:95–100.
- ••Critical background review for this approach to COPD.
- PETERSON JT: Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail. Rev. (2004) 9(1):63–79.
- •Timely review of the pitfalls with MMP inhibitors.